230 related articles for article (PubMed ID: 34080659)
1. Sensitizing TRAIL‑resistant A549 lung cancer cells and enhancing TRAIL‑induced apoptosis with the antidepressant amitriptyline.
Zinnah KMA; Park SY
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080659
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of autophagy flux by sertraline attenuates TRAIL resistance in lung cancer via death receptor 5 upregulation.
Zinnah KMA; Seol JW; Park SY
Int J Mol Med; 2020 Aug; 46(2):795-805. PubMed ID: 32626921
[TBL] [Abstract][Full Text] [Related]
3. Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo.
Qiao X; Wang X; Shang Y; Li Y; Chen SZ
Cancer Commun (Lond); 2018 Jul; 38(1):43. PubMed ID: 29970185
[TBL] [Abstract][Full Text] [Related]
4. Icariin sensitizes human colon cancer cells to TRAIL‑induced apoptosis via ERK‑mediated upregulation of death receptors.
Kim B; Seo JH; Lee KY; Park B
Int J Oncol; 2020 Mar; 56(3):821-834. PubMed ID: 32124960
[TBL] [Abstract][Full Text] [Related]
5. Autophagy flux inhibition mediated by celastrol sensitized lung cancer cells to TRAIL‑induced apoptosis via regulation of mitochondrial transmembrane potential and reactive oxygen species.
Nazim UM; Yin H; Park SY
Mol Med Rep; 2019 Feb; 19(2):984-993. PubMed ID: 30569150
[TBL] [Abstract][Full Text] [Related]
6. IFN‑β sensitizes TRAIL‑induced apoptosis by upregulation of death receptor 5 in malignant glioma cells.
Yoshimura S; Sano E; Hanashima Y; Yamamuro S; Sumi K; Ueda T; Nakayama T; Hara H; Yoshino A; Katayama Y
Oncol Rep; 2019 Dec; 42(6):2635-2643. PubMed ID: 31638255
[TBL] [Abstract][Full Text] [Related]
7. Telmisartan generates ROS-dependent upregulation of death receptor 5 to sensitize TRAIL in lung cancer via inhibition of autophagy flux.
Rasheduzzaman M; Moon JH; Lee JH; Nazim UM; Park SY
Int J Biochem Cell Biol; 2018 Sep; 102():20-30. PubMed ID: 29929000
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of c‑FLIP and upregulation of DR‑5 by cantharidin sensitizes TRAIL‑mediated apoptosis in prostate cancer cells via autophagy flux.
Nazim UM; Yin H; Park SY
Int J Mol Med; 2020 Jul; 46(1):280-288. PubMed ID: 32319535
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA induces TRAIL sensitization of human lung cancer cells through selective ER stress induction.
Kim EO; Kang SE; Im CR; Lee JH; Ahn KS; Yang WM; Um JY; Lee SG; Yun M
Int J Oncol; 2016 May; 48(5):2205-12. PubMed ID: 26983803
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation.
Chen L; Meng Y; Sun Q; Zhang Z; Guo X; Sheng X; Tai G; Cheng H; Zhou Y
Cell Death Dis; 2016 Aug; 7(8):e2334. PubMed ID: 27512955
[TBL] [Abstract][Full Text] [Related]
11. Luteolin sensitizes human liver cancer cells to TRAIL‑induced apoptosis via autophagy and JNK‑mediated death receptor 5 upregulation.
Nazim UM; Park SY
Int J Oncol; 2019 Feb; 54(2):665-672. PubMed ID: 30431076
[TBL] [Abstract][Full Text] [Related]
12. The herbal compound cryptotanshinone restores sensitivity in cancer cells that are resistant to the tumor necrosis factor-related apoptosis-inducing ligand.
Tse AK; Chow KY; Cao HH; Cheng CY; Kwan HY; Yu H; Zhu GY; Wu YC; Fong WF; Yu ZL
J Biol Chem; 2013 Oct; 288(41):29923-33. PubMed ID: 23986445
[TBL] [Abstract][Full Text] [Related]
13. 3‑Bromopyruvate sensitizes human breast cancer cells to TRAIL‑induced apoptosis via the phosphorylated AMPK‑mediated upregulation of DR5.
Chen Y; Wei L; Zhang X; Liu X; Chen Y; Zhang S; Zhou L; Li Q; Pan Q; Zhao S; Liu H
Oncol Rep; 2018 Nov; 40(5):2435-2444. PubMed ID: 30132536
[TBL] [Abstract][Full Text] [Related]
14. Andrographolide sensitizes human renal carcinoma cells to TRAIL‑induced apoptosis through upregulation of death receptor 4.
Bi R; Deng Y; Tang C; Xuan L; Xu B; Du Y; Wang C; Wei W
Oncol Rep; 2020 Nov; 44(5):1939-1948. PubMed ID: 33000263
[TBL] [Abstract][Full Text] [Related]
15. 5-allyl-7-gen-difluoromethoxychrysin enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells.
Xie ZH; Quan MF; Liu F; Cao JG; Zhang JS
BMC Cancer; 2011 Jul; 11():322. PubMed ID: 21801359
[TBL] [Abstract][Full Text] [Related]
16. Neferine treatment enhances the TRAIL‑induced apoptosis of human prostate cancer cells via autophagic flux and the JNK pathway.
Nazim UM; Yin H; Park SY
Int J Oncol; 2020 May; 56(5):1152-1161. PubMed ID: 32319589
[TBL] [Abstract][Full Text] [Related]
17. Lucanthone, Autophagy Inhibitor, Enhances the Apoptotic Effects of TRAIL through miR-216a-5p-Mediated DR5 Upregulation and DUB3-Mediated Mcl-1 Downregulation.
Yoon JY; Woo SM; Seo SU; Song SR; Lee SG; Kwon TK
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008442
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells.
Yan S; Qu X; Xu C; Zhu Z; Zhang L; Xu L; Song N; Teng Y; Liu Y
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1279-89. PubMed ID: 22447040
[TBL] [Abstract][Full Text] [Related]
19. Azadirone, a limonoid tetranortriterpene, induces death receptors and sensitizes human cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through a p53 protein-independent mechanism: evidence for the role of the ROS-ERK-CHOP-death receptor pathway.
Gupta SC; Francis SK; Nair MS; Mo YY; Aggarwal BB
J Biol Chem; 2013 Nov; 288(45):32343-32356. PubMed ID: 24078627
[TBL] [Abstract][Full Text] [Related]
20. Genistein enhances TRAIL-induced cancer cell death via inactivation of autophagic flux.
Nazim UM; Park SY
Oncol Rep; 2015 Nov; 34(5):2692-8. PubMed ID: 26352862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
